Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» ARIAD Pharmaceuticals: Ponatinib Approval Anticipated In Second-Line CML
ARIAD Pharmaceuticals: Ponatinib Approval Anticipated In Second-Line CML
ARIAD Pharmaceuticals: Ponatinib Approval Anticipated In Second-Line CML
Submitted by
admin
on October 1, 2012 - 11:27am
Source:
Seeking Alpha
News Tags:
Ponatinib
CML
Ariad Pharmaceuticals
Pfizer
Bristol-Myers Squibb
Novartis
Headline:
ARIAD Pharmaceuticals: Ponatinib Approval Anticipated In Second-Line CML
Do Not Allow Advertisers to Use My Personal information
